byiShook Opinion
Oct 7, 2024 - 12:45
Scholar Rock stock catapulted by triple digits Monday after its spinal muscular atrophy treatment succeeded in a Phase 3 study. The post Scholar Rock Jumps 320% On Final-Phase Win In Spinal Muscular Atrophy appeared first on Investor's Business Daily.
Scholar Rock stock catapulted by triple digits Monday after its spinal muscular atrophy treatment succeeded in a Phase 3 study.
The post Scholar Rock Jumps 320% On Final-Phase Win In Spinal Muscular Atrophy appeared first on Investor's Business Daily.